Clinical Endocrinologists (AACE) And American College Of Endocrinology (ACE) Announce Groundbreaking Framework To Combat Obesity Epidemic

| April 24, 2014

April 2014

WASHINGTON, D.C.—When obesity thought leaders representing public and private stakeholders convened here this past weekend for The AACE/ACE Consensus Conference of Obesity: Building an Evidence Base for Comprehensive Action, it was the realization of a years-long quest by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) to identify the myriad issues surrounding, and necessary steps for solving, the epidemic of obesity.

The AACE/ACE revealed the outcome of the conference: an evidence-based, multi-dimensional, comprehensive framework that will become an action plan of attack.

“Key findings include the need for an improved definition of obesity, highquality research including evaluation of a complications-centric clinical approach to obesity, and better understanding of reimbursement mechanisms,” said conference chair W. Timothy Garvey, MD.

“We also need to address the value associated with obesity prevention and management, increased nutrition and obesity education, and enhanced public awareness and health literacy,” said conference co-chair Alan J. Garber, MD, PhD, FACE.

Daniel Einhorn, MD, FACP, FACE, ACE president said, “This is the most under-reimbursed major disease in the U.S.A.”

“Next steps include translating these findings into actionable recommendations for individual patients that are likely to succeed and developing logistics for effective implementation,” added AACE President and co-chair Jeffrey I. Mechanick, MD, FACP, FACE, FACN, ECNU.

The framework was derived from five fundamental questions intensely debated by participants divided into the following areas: biomedical; government and regulation; health industry and economics; and society, education and research.

The five questions were:

1. What is obesity?

2. What options are available for obesity management?

3. What is the optimal use of therapeutic modalities?

4. Can the framework be cost-effective?

5. What are the knowledge gaps and how can they be filled?

AACE’s Board of Directors declared obesity a disease state in July 2011. The association also was the author of the resolution adopted in June 2013 by the American Medical Association (AMA) House of Delegates recognizing obesity as a disease.

To learn more about the AACE, visit

For more information about the ACE, visit

For more information about the endocrine system, visit the ACE-sponsored patient education website at



Category: News and Trends, Past Articles

Comments are closed.